Impact of AR Glasses on Children's Behavior During Dental Nerve Blocks
Launched by DAMASCUS UNIVERSITY · Dec 5, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how augmented reality (AR) glasses can help manage pain and anxiety in children aged 7 to 9 during a dental procedure called an inferior alveolar nerve block, which involves giving an injection to numb the area. The trial involves four groups of children: one group will watch animated movies on a mobile device, while others will use AR glasses to either watch movies or play video games before and during the procedure. The goal is to see if these methods can help children feel more comfortable and behave better while receiving dental treatment.
To participate in this study, children must be between 7 and 9 years old and show positive behavior during dental visits. They should not have had any previous experience with dental anesthesia or AR technology, and they should not have any neurological, psychological, or hearing issues. Children will be assessed through various methods, including pictures and scales to measure their feelings and behaviors. It's important to know that children who refuse to wear the glasses or are in acute dental pain will not be eligible for this trial.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Children aged between 7 and 9 years
- • 2. Children categorized as having positive or definitely positive behavior on Frankl behavioral scale.
- • 3. Children whose dental treatment requires an IANB injection.
- • 4. Children with neither previous dental anesthesia experience nor augmented reality experience.
- • 5. Children who do not suffer from any neurological, psychological or hearing disorders
- Exclusion Criteria:
- • 1. Children who refuse to put the glasses on.
- • 2. Children suffering from acute dental pain.
- • 3. Children suffering from auditory or visual disturbances
About Damascus University
Damascus University, a prestigious institution located in Syria, is committed to advancing medical research and healthcare innovation through its clinical trial initiatives. With a focus on fostering collaboration between academia and clinical practice, the university aims to enhance the understanding of various medical conditions and improve patient outcomes. By leveraging its extensive network of researchers, healthcare professionals, and state-of-the-art facilities, Damascus University strives to contribute to the global body of knowledge in the medical field and support the development of effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Damascus, , Syrian Arab Republic
Patients applied
Trial Officials
Mai Maher Albaal, DDS
Principal Investigator
Department of Pediatric Dentistry, Faculty of Dentistry, University of Damascus, Damascus, Syria
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported